Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Sutro Biopharma
STRO
$340M
| $1.87M | ﹤0.01% |
101,521
+18,711
| +23% | +$571K |
|
2102
Crane NXT
CXT
$2.97B
| $1.86M | ﹤0.01% |
31,900
+24,300
| +320% | +$1.4M |
|
2103
LCNB Corp
LCNB
$283M
| $1.86M | ﹤0.01% |
122,716
+7,500
| +7% | +$120K |
|
2104
POET Technologies
POET
$1.65B
| $1.86M | ﹤0.01% |
311,816
+282,176
| +952% | +$1.25M |
|
2105
Princeton Bancorp
BPRN
$296M
| $1.85M | ﹤0.01% |
53,688
+5,065
| +10% | +$186K |
|
|
HOUS
2106
DELISTED
Anywhere Real Estate
HOUS
| $1.85M | ﹤0.01% |
560,120
+184,120
| +49% | +$789K |
|
2107
State Street SPDR S&P Metals & Mining ETF
XME
$4.53B
| $1.84M | ﹤0.01% |
32,500
-21,300
| -40% | -$1.37M |
|
2108
Editas Medicine
EDIT
$433M
| $1.84M | ﹤0.01% |
+1,451,049
| New | +$3.7M |
|
|
HEPS
2109
D-Market Electronic Services & Trading
HEPS
$997M
| $1.84M | ﹤0.01% |
607,700
-506,100
| -45% | -$1.51M |
|
2110
Immersion
IMMR
$249M
| $1.84M | ﹤0.01% |
210,848
-637,465
| -75% | -$5.57M |
|
2111
WesBanco
WSBC
$4.09B
| $1.83M | ﹤0.01% |
56,347
-161,025
| -74% | -$5.33M |
|
2112
Schwab US Mid-Cap ETF
SCHM
$15.4B
| $1.83M | ﹤0.01% |
+66,100
| New | +$1.88M |
|
|
VZLA
2113
Vizsla Silver
VZLA
$1.32B
| $1.83M | ﹤0.01% |
1,070,061
+790,161
| +282% | +$1.52M |
|
|
YALA
2114
Yalla Group
YALA
$832M
| $1.83M | ﹤0.01% |
450,200
-23,100
| -5% | -$99.3K |
|
2115
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.84B
| $1.83M | ﹤0.01% |
25,300
-6,000
| -19% | -$456K |
|
2116
Chefs' Warehouse
CHEF
$4.45B
| $1.83M | ﹤0.01% |
37,022
+27,022
| +270% | +$1.18M |
|
|
SUP
2117
DELISTED
Superior Industries International
SUP
| $1.82M | ﹤0.01% |
894,235
-11,300
| -1% | -$28.5K |
|
2118
Dimensional US Core Equity Market ETF
DFAU
$12.9B
| $1.82M | ﹤0.01% |
+45,000
| New | +$1.84M |
|
|
WSR
2119
DELISTED
Whitestone REIT
WSR
| $1.82M | ﹤0.01% |
128,484
+7,400
| +6% | +$106K |
|
2120
Heron Therapeutics
HRTX
$63.9M
| $1.82M | ﹤0.01% |
1,188,800
-819,398
| -41% | -$1.33M |
|
2121
United-Guardian
UG
$32.8M
| $1.82M | ﹤0.01% |
190,163
+7,800
| +4% | +$89.6K |
|
2122
iShares Global Energy ETF
IXC
$2.77B
| $1.82M | ﹤0.01% |
47,600
+31,900
| +203% | +$1.31M |
|
2123
Perimeter Solutions
PRM
$5.55B
| $1.81M | ﹤0.01% |
141,900
+131,900
| +1,319% | +$1.72M |
|
2124
First Community Bankshares
FCBC
$936M
| $1.81M | ﹤0.01% |
43,494
-4,500
| -9% | -$198K |
|
2125
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.9B
| $1.81M | ﹤0.01% |
+23,800
| New | +$1.78M |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.